Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A surface-based technique for mapping homotopic interhemispheric connectivity: Development, characterization, and clinical application.
Astrocytic IL-6 Influences the Clinical Symptoms of EAE in Mice.
Cost-Utility Analysis (cua) Of First-Line Disease-Modifying Treatments (DMT) Versus Best Supportive Care (Bsc) In Finnish Relapsing-Remitting Multiple Sclerosis (RRMS) Patients.
Construct Validity of the Four Square Step Test in Multiple Sclerosis.
Boosting CNS axon regeneration by circumventing limitations of natural cytokine signaling.
Icariin exerts estrogen-like activity in ameliorating EAE via mediating estrogen receptor β, modulating HPA function and glucocorticoid receptor expression.
The Cost Burden of Switching Patients with Relapsing-Remitting Multiple Sclerosis from Glatiramer Acetate To Newly-Approved Disease Modifying Therapies.
[The biological role of sulfatides].
Co-occurrence of multiple sclerosis and Parkinson disease.
Sodium intake is associated with increased disease activity in multiple sclerosis.
A review of Neuropharmacology Effects of Nigella sativa and Its Main Component, Thymoquinone.
Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod.
Evaluation of Methods for the Inclusion of Real World Evidence in Network Meta-Analysis - A Case Study in Multiple Sclerosis.
The effect of postpartum intravenous immunoglobulins on the relapse rate among patients with multiple sclerosis.
The association of IL-18 gene promoter polymorphisms and the levels of serum IL-18 on the risk of multiple sclerosis.
Short Term Reproducibility of a High Contrast 3-D Isotropic Optic Nerve Imaging Sequence in Healthy Controls.
MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis.
Glial progenitor cell-based treatment of the childhood leukodystrophies.
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
Astrocytes in multiple sclerosis.
The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.
Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.
Modelling the Persistence of Disease-Modifying Drug Treatment (DMT) and its Independent Drivers in Finnish Multiple Sclerosis (MS) Patients: Parametric Survival Modelling.
Health Care Utilization and Costs of Medicaid Program Services for Patients Diagnosed with Multiple Sclerosis.
Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy.

Pages